rs201392911
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000400.4(ERCC2):c.2083C>T(p.Arg695Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000400.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC2 | NM_000400.4 | c.2083C>T | p.Arg695Cys | missense_variant | Exon 22 of 23 | ENST00000391945.10 | NP_000391.1 | |
ERCC2 | XM_011526611.3 | c.2005C>T | p.Arg669Cys | missense_variant | Exon 21 of 22 | XP_011524913.1 | ||
ERCC2 | XR_001753633.3 | n.2116C>T | non_coding_transcript_exon_variant | Exon 22 of 24 | ||||
ERCC2 | XR_007066680.1 | n.2038C>T | non_coding_transcript_exon_variant | Exon 21 of 23 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251314Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135864
GnomAD4 exome AF: 0.000178 AC: 260AN: 1461802Hom.: 0 Cov.: 37 AF XY: 0.000183 AC XY: 133AN XY: 727208
GnomAD4 genome AF: 0.000131 AC: 20AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
- -
Variant summary: ERCC2 c.2083C>T (p.Arg695Cys) results in a non-conservative amino acid change located in the ATP-dependent helicase, C-terminal domain (IPR006555) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 251314 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in ERCC2 causing Xeroderma Pigmentosum (0.00014 vs 0.00061), allowing no conclusion about variant significance. c.2083C>T has been reported in the literature in individuals affected with medulloblastoma (Trubicka_2017) and Osteosarcoma (Zhang_2015). These reports do not provide unequivocal conclusions about association of the variant with Xeroderma Pigmentosum or Trichothiodystrophy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters have assessed this variant since 2014: all have classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
- -
Xeroderma pigmentosum, group D Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 695 of the ERCC2 protein (p.Arg695Cys). This variant is present in population databases (rs201392911, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ERCC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 134101). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ERCC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at